HCAT vs CTEV

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 13, 2026

HCAT

46.4
AI Score
VS
HCAT Wins

CTEV

37.1
AI Score

Investment Advisor Scores

HCAT

46score
Recommendation
HOLD

CTEV

37score
Recommendation
SELL

AI Analyst Insights

Detailed Metrics Comparison

Metric HCAT CTEV Winner
Forward P/E 7.764 5.8411 CTEV
PEG Ratio 0 0 Tie
Revenue Growth -12.7% 6.6% CTEV
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 46.4/100 37.1/100 HCAT
Profit Margin -90.6% -28.5% CTEV
Beta 1.00 1.00 Tie
AI Recommendation HOLD SELL HCAT

Relative Price Performance (Last 90 Days)

HCAT 1M: -23.9% · 3M: +18.6% CTEV 1M: +60.2% · 3M: +58.3%

Current Technical Phase

HCAT

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 32

RSI (14): 32.4 · Price: $1.53

CTEV

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (9.6% over 20 days), RSI 61

RSI (14): 61.4 · Price: $37.27

Fundamentals Snapshot

Metric HCAT CTEV
Market Cap
Forward P/E 38.4 5.1
Trailing P/E
Revenue (TTM)
Revenue Growth -0.1% 0.1%
Gross Margin 0.5% 0.7%
Operating Margin -0.1% 0.1%
EPS -3.54 -16.37
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, HCAT is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.